[{"Assets_0_Q2_USD":443997000.0,"CommonStockSharesOutstanding_0_Q2_shares":46248945.0,"EarningsPerShareBasic_2_Q2_USD":0.06,"EarningsPerShareBasic_1_Q2_USD":0.04,"EarningsPerShareDiluted_2_Q2_USD":0.06,"EarningsPerShareDiluted_1_Q2_USD":0.04,"NetIncomeLoss_2_Q2_USD":2865000.0,"NetIncomeLoss_1_Q2_USD":1972000.0,"StockholdersEquity_0_Q2_USD":333314000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":47962000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":47866000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":46047000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":46025000.0,"Ticker":"AMPH","CIK":"1297184","name":"AMPHASTAR PHARMACEUTICALS, INC.","OfficialName":"Amphastar Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20170630","fy":"2017.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1905609900.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20170809"}]